TITLE

HIV and the Millennium Development Goals

AUTHOR(S)
Prendergast, Andrew J.; Essajee, Shaffiq; Penazzato, Martina
PUB. DATE
February 2015
SOURCE
Archives of Disease in Childhood;Feb2015, Vol. 100 Issue Supp1, ps48
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Millennium Development Goal (MDG) 6 has two HIV/ AIDS commitments: to have halted and begun to reverse the spread of HIV/AIDS by 2015 and to ensure access to treatment among all those in need by 2010. Given the almost universal lack of access to HIV testing, prevention and treatment for children in high prevalence countries in 2000, the achievements of the past 15 years have been extraordinary, fuelled by massive donor investment, strong political commitment and ambitious global targets; however, MDG 6 is some way from being attained. Prevention of mother-to-child transmission (PMTCT) services have expanded enormously, with new infections among children falling by 58% between 2002 and 2013. There has been a shift towards initiation of lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women, although low HIV testing rates in pregnancy, suboptimal PMTCT coverage and poor retention in care remain barriers to achieving HIV elimination among children. Early infant diagnosis has expanded substantially but, in 2013, only 44% of all HIV-exposed infants were tested before 2 months of age. Diagnosis of HIV, therefore, frequently occurs late, leading to delays in ART initiation. By the end of 2013, approximately 760000 children were receiving ART, leading to 40% decline in AIDS-related mortality. However, only 24% of HIV-infected children were receiving ART, compared with 36% of adults, leading to a 'treatment gap'. In this review, we summarise progress and remaining challenges in reaching MDG 6 and discuss future strategies to achieve the ambitious goals of paediatric HIV elimination and universal access to treatment.
ACCESSION #
100822176

 

Related Articles

  • Attitudes of People in the UK with HIV Who Are Antiretroviral (ART) Naïve to Starting ART at High CD4 Counts for Potential Health Benefit or to Prevent HIV Transmission. Rodger, Alison J.; Phillips, Andrew; Speakman, Andrew; Gilson, Richard; Fisher, Martin; Wilkins, Ed; Anderson, Jane; Johnson, Margaret; O'Connell, Rebecca; Collins, Simon; Elford, Jonathan; Sherr, Lorraine; Lampe, Fiona C. // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Objective: To assess if a strategy of early ART to prevent HIV transmission is acceptable to ART naïve people with HIV with high CD4 counts. Design: ASTRA is a UK multicentre, cross sectional study of 3258 HIV outpatients in 2011/12. A self-completed questionnaire collected sociodemographic,...

  • Essential medicines for children. Hoppu, Kalle; Ranganathan, Shalini Sri // Archives of Disease in Childhood;Feb2015, Vol. 100 Issue Supp1, ps38 

    Millions of children die every year before they reach the age of 5 years, of conditions largely treatable with existing medicines. The WHO Model List of Essential Medicines was launched in 1977 to make the most necessary drugs available to populations whose basic health needs could not be met by...

  • Preface. Zablotska, Iryna; Ananworanich, Jintanat; Kamarulzaman, Adeeba; Mayer, Ken; Poynten, Mary; Whittaker, Bill; de Wit, John; Wright, Edwina // Sexual Health (14485028);2014, Vol. 11 Issue 2, pi 

    An introduction is presented in which the editor discusses various reports within the issue on topics including prevention of HIV infection, the use of antiretrovirals in HIV treatment and treatment-based prevention approaches.

  • Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997–2011. Bontell, Irene; Häggblom, Amanda; Bratt, Göran; Albert, Jan; Sönnerborg, Anders // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Objective: Describe trends in antiretroviral treatments and drug resistance mutations among Swedish HIV-patients over time 1997–2011. Methods: Treatment histories, viral sequences, and demographic and clinical data were retrieved from the national database InfCareHIV. All...

  • Correction: HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy? null, null // PLoS ONE;Jan2015, Vol. 10 Issue 1, p1 

    No abstract available.

  • Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy. Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Background: It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods: The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead...

  • Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts. Krastinova, Evguenia; Seng, Remonie; Yeni, Patrick; Viard, Jean-Paul; Vittecoq, Daniel; Lascoux-Combe, Caroline; Fourn, Erwan; Pahlavan, Golriz; Delfraissy, Jean François; Meyer, Laurence // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Objective: Guidelines for initiating HIV treatment are regularly revised. We explored how physicians in France have applied these evolving guidelines for ART initiation over the last decade in two different situations: chronic (CHI) and primary HIV-1 infection (PHI), since specific...

  • Long-Term CD4+ Cell Count in Response to Combination Antiretroviral Therapy. Luz, Paula M.; Grinsztejn, Beatriz; Velasque, Luciane; Pacheco, Antonio G.; Veloso, Valdilea G.; Moore, Richard D.; Struchiner, Claudio J. // PLoS ONE;Apr2014, Vol. 9 Issue 4, p1 

    Objective: There is a continuous debate on how to adequately evaluate long-term CD4+ cell count in response to combination antiretroviral therapy (ART) among human immunodeficiency virus (HIV)-infected individuals. Our study evaluated the long-term CD4+ cell count response (up to ten years)...

  • Technical Performance Evaluation of the MyT4 Point of Care Technology for CD4+ T Cell Enumeration. Mwau, Matilu; Kadima, Silvia; Mwende, Joy; Adhiambo, Maureen; Akinyi, Catherine; Prescott, Marta; Lusike, Judi; Hungu, Jackson; Vojnov, Lara // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Objective: Though absolute CD4+ T cell enumeration is the primary gateway to antiretroviral therapy initiation for HIV-positive patients in all developing countries, patient access to this critical diagnostic test is relatively poor. We technically evaluated the performance of a newly developed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics